IQ Corporation is a biopharmaceutical company focusing on the development of immunology based therapeutics and diagnostics. Therapeutic fully human antibodies are generated to treat infections, cancer and neurodegenerative diseases. Diagnostic tests are developed, manufactured and marketed worldwide.
IQ Corporation is a global biopharmaceutical company based in The Netherlands. It is IQ‘s mission to contribute to human healthcare by the development and worldwide commercialization of innovative products for diagnosis and therapy.
IQ Products
In the past few years IQ has established a profitable specialized diagnostic business unit named IQ Products with world-wide sales. Focus areas are transplant related diagnosis, sepsis and perinatal diagnosis. New products are developed in-house and in close cooperation with international universities and innovative companies in order to rapidly expand our business. IQ Products has direct sales in the Netherlands and Germany and a worldwide network of distributors in over 45 countries.
http://www.iqproducts.nl
IQ Therapeutics
Our therapeutic business unit IQ Therapeutics aims to deliver “Instant Immunity” based on its novel and proprietary human antibody-based technology. Focus is on biodefense and infectious disease applications with IQ-DAA as our lead product for treatment of Anthrax infections. IQ-DAA is currently in clinical phase I.
http://www.iqtherapeutics.nl
Business model
IQ’s business model is the combination of profitable diagnostics in IQ Products and challenging therapeutic developments in IQ Therapeutics. IQ is privately owned and employs currently a team of 30 people in research, development, manufacturing and marketing & sales.
Subscribe to our RSS Feed 